Live tape
Top 8, mentions 7d6,547GOOGL1,216 mentions▲ +0.03NKE1,047 mentions+0.01AAPL944 mentions▲ +0.06NVDA895 mentions▲ +0.08TSLA736 mentions▲ +0.06META653 mentions▲ +0.05LULU553 mentions▲ +0.03VOO503 mentions▲ +0.09

Equity · Healthcare

AVTR

Avantor, Inc. · NYSE

$14.88 −2.59% 1D Finazon · prior-day close · Sep 9, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$16 $8 12 Jun 9 Sep

The line runs $9.39 on 12 June through $14.88 on 9 September, on a scale from $8 to $16. Days the market did not trade hold the previous close, flat.

The chart above plots the price of AVTR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $9.39 on 12 June 2026 through $14.88 on 9 September 2026.

Market cap $10.2B
52-week range $7.41 – $15.61
Avg volume 1.7M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 10, 2026

AVTR insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 18 Aug 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 5

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
18 Aug 2026 Ligner Emmanuel President and CEO Tax withheld 29,803 $397K
14 Aug 2026 Hankamer Brittany EVP, Chief HR Officer Tax withheld 181 $2K
31 Jul 2026 Eck Steven W SVP & Chief Accounting Officer Tax withheld 1,385 $19K
24 Jul 2026 Sokenu Claudius EVP, Chief Legal & Compliance Tax withheld 1,201 $14K
21 Jun 2026 Walker Corey President, VWR Dist. & Servs. Tax withheld 3,010 $29K

AVTR reported financials

SEC EDGAR XBRL

AVTR reported revenue of $6.6B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$530.2M.

Figure Reported Period
Revenue $6.6B 31 Dec 2025 fiscal year
Net income −$530.2M 31 Dec 2025 fiscal year
Diluted EPS −$0.78 31 Dec 2025 fiscal year
Total assets $11.7B 31 Mar 2026 at period end
Total equity $5.6B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

AVTR earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.06 $1.58B
31 Dec 2025 FY 2025 $-0.78 $6.55B
30 Sep 2025 Q3 2025 $-1.04 $1.62B
30 Jun 2025 Q2 2025 $0.09 $1.68B
31 Mar 2025 Q1 2025 $0.09 $1.58B
31 Dec 2024 FY 2024 $1.04 $6.78B
30 Sep 2024 Q3 2024 $0.08 $1.71B
30 Jun 2024 Q2 2024 $0.14 $1.70B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

AVTR institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a AVTR position for the quarter ended 30 Jun 2026 — a combined $364.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Marshall Wace Added +281.9% shares 13,130,158 $130.0M
AQR Capital Management Added +138.9% shares 11,627,566 $115.1M
D. E. Shaw & Co. Trimmed −27.0% shares 9,571,523 $94.8M
Man Group Added +62.1% shares 990,477 $9.8M
Millennium Management Trimmed −69.1% shares 753,575 $7.5M
Citadel Advisors Trimmed −29.9% shares 399,147 $4.0M
Bridgewater Associates Added +134.9% shares 301,219 $3.0M

Source: SEC EDGAR 13F filings

AVTR fails-to-deliver

SEC CNS data

On 11 Aug 2026, 23 shares of AVTR failed to deliver (about $316).

Settlement date Shares failed Notional % of shares out
11 Aug 2026 23 $316 <0.001%
07 Aug 2026 32 $422 <0.001%
04 Aug 2026 2,151 $29K <0.001%
03 Aug 2026 41 $565 <0.001%
29 Jul 2026 65 $807 <0.001%
27 Jul 2026 19,841 $227K 0.003%

Source: SEC fails-to-deliver (CNS) data